title: eEOC-mediated modulation of endothelial autophagy, senescence, and EnMT in murine diabetic nephropathy.
abstract: Diabetic nephropathy is the most frequent single cause of end-stage renal disease in our society. Microvascular damage is a key event in diabetes-associated organ malfunction. Early endothelial outgrowth cells (eEOCs) act protective in murine acute kidney injury. The aim of the present study was to analyze consequences of eEOC treatment of murine diabetic nephropathy with special attention on endothelial-to-mesenchymal transdifferentiation, autophagy, senescence, and apoptosis. Male C57/Bl6N mice (8-12 wk old) were treated with streptozotocin for 5 consecutive days. Animals were injected with untreated or bone morphogenetic protein (BMP)-5-pretreated syngeneic murine eEOCs on days 2 and 5 after the last streptozotocin administration. Four, eight, and twelve weeks later, animals were analyzed for renal function, proteinuria, interstitial fibrosis, endothelial-to-mesenchymal transition, endothelial autophagy, and senescence. In addition, cultured mature murine endothelial cells were investigated for autophagy, senescence, and apoptosis in the presence of glycated collagen. Diabetes-associated renal dysfunction (4 and 8 wk) and proteinuria (8 wk) were partly preserved by systemic cell treatment. At 8 wk, antiproteinuric effects were even more pronounced after the injection of BMP-5-pretreated cells. The latter also decreased mesenchymal transdifferentiation of the endothelium. At 8 wk, intrarenal endothelial autophagy (BMP-5-treated cells) and senescence (native and BMP-5-treated cells) were reduced. Autophagy and senescence in/of cultured mature endothelial cells were dramatically reduced by eEOC supernatant (native and BMP-5). Endothelial apoptosis decreased after incubation with eEOC medium (native and BMP-5). eEOCs act protective in diabetic nephropathy, and such effects are significantly stimulated by BMP-5. The cells modulate endothelial senescence, autophagy, and apoptosis in a protective manner. Thus, the renal endothelium could serve as a therapeutic target in diabetes-associated kidney dysfunction.
authors: Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen, Germany; and d.patschan@gmail.com.
authors: D
authors: D
authors: Patschan
authors: Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen, Germany; and.
authors: K
authors: K
authors: Schwarze
authors: Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen, Germany; and.
authors: E
authors: E
authors: Henze
authors: Department of Pathology, Medical School Hannover, Hannover, Germany.
authors: J U
authors: JU
authors: Becker
authors: Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen, Germany; and.
authors: S
authors: S
authors: Patschan
authors: Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen, Germany; and.
authors: G A
authors: GA
authors: Müller
mesh_terms: D000818:Animals; D017209:Apoptosis; D001343:Autophagy; D055417:Bone Morphogenetic Protein 5 / Q000502:physiology*; D054338:Cell Transdifferentiation; D016922:Cellular Senescence; D003928:Diabetic Nephropathies / Q000628:therapy*; D042783:Endothelial Cells / Q000502:physiology / Q000637:transplantation*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011507:Proteinuria / Q000517:prevention & control
chemical_list: C525815:Bmp5 protein, mouse; D055417:Bone Morphogenetic Protein 5
keywords: autophagy; bone morphogenetic protein-5; diabetic nephropathy; early endothelial outgrowth cells; mesenchymal transition of endothelial cells; senescence